Currently out of the existing stock ratings of Allison Bratzel, 74 are a BUY (84.09%), 14 are a HOLD (15.91%).

Allison Bratzel

Work Performance Price Targets & Ratings Chart

Analyst Allison Bratzel, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 57.04% that have a potential upside of 60.33% achieved within 226 days.

Allison Bratzel’s has documented 172 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SRRK, Scholar Rock Holding Corp at 15-Sep-2026.

Wall Street Analyst Allison Bratzel

Analyst best performing recommendations are on ABVX (ABIVAX SA).
The best stock recommendation documented was for ABVX (ABIVAX SA) at 7/2/2025. The price target of $42 was fulfilled within 21 days with a profit of $34.24 (441.24%) receiving and performance score of 210.11.

Average potential price target upside

ARGX argenx NV ADR ENGN enGene Holdings HUMA Humacyte INCY yte IONS Ionis Pharmaceuticals MGTX MeiraGTx Holdings PLC REPL Replimune Group RIGL Rigel Pharmaceuticals ROIV Roivant Sciences Ltd SRRK Scholar Rock Holding Corp TVTX Travere Therapeutics TYRA Tyra Biosciences AKBA Akebia Ther ABCL Abcellera Biologics ABVX Abivax SA ARDX Ardelyx BMRN Biomarin Pharmaceutical SLDB Solid Biosciences LLC COGT Cogent Biosciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Aug-2025

$1025

$155.28 (17.85%)

$1100

Buy Since 13-Sep-2018

$1356

$486.28 (55.91%)

$1415

8 days ago
(13-Oct-2026)

20/27 (74.07%)

$537.7 (65.71%)

198

Buy Since 16-Jul-2023

$1078

$208.28 (23.95%)

$1175

10 days ago
(11-Oct-2026)

5/8 (62.5%)

$252.97 (30.66%)

103

Buy Since 22-Jul-2024

$1038

$168.28 (19.35%)

$1037

10 days ago
(11-Oct-2026)

11/13 (84.62%)

$212.97 (25.81%)

117

Buy Since 15-Nov-2017

$1150

$280.28 (32.23%)

$1150

1 months 14 days ago
(07-Sep-2026)

36/39 (92.31%)

$142.93 (14.19%)

118

Show more analysts

Please expand the browser size to see the chart

Which stock is Allison Bratzel most bullish on?

Potential upside of $345.28 has been obtained for ARGX (ARGENX NV ADR)

Which stock is Allison Bratzel most reserved on?

Potential downside of $2.28 has been obtained for RIGL (RIGEL PHARMACEUTICALS)

What Year was the first public recommendation made by Allison Bratzel?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?